subject: GTOPDB:8269

subject_name: oblimersen


subject: CHEMBL.COMPOUND:CHEMBL2108324

subject_name: OBLIMERSEN

object_name: Solid Neoplasm

tested_intervention: unsure


subject: UMLS:C0935954

subject_name: Genasense


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C5847498

subject_name: Irinotecan liposome injection

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: Abdominal pain


subject: PUBCHEM.COMPOUND:66964417

object_name: Abdominal Pain, CTCAE


subject: PUBCHEM.COMPOUND:66964417

object_name: Nausea, CTCAE_5


subject: PUBCHEM.COMPOUND:66964417

object_name: Nausea


subject: PUBCHEM.COMPOUND:66964417

object_name: Nausea, CTCAE_3


subject: PUBCHEM.COMPOUND:66964417

object_name: Vomiting, CTCAE


subject: PUBCHEM.COMPOUND:66964417

object_name: Vomiting


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: CHEBI:41139

subject_name: BETAINE

object_name: Inflammation

tested_intervention: yes


subject: CHEBI:41139

object_name: Abnormality of temperature regulation


subject: CHEBI:41139

object_name: Dehydration


subject: UMLS:C2713112

object_name: skin basal cell carcinoma


subject: UMLS:C2713112

object_name: Recurrent Skin Carcinoma


subject: UMLS:C0058423

subject_name: Diprophos

object_name: Sprain


subject: CHEMBL.COMPOUND:CHEMBL3707359

subject_name: DAXIBOTULINUMTOXINA

object_name: clonic hemifacial spasm


subject: CHEMBL.COMPOUND:CHEMBL3707359

object_name: Hemifacial spasm


subject: CHEMBL.COMPOUND:CHEMBL3707359

object_name: blepharospasm


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: cardiovascular disorder


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: PUBCHEM.COMPOUND:126961754

subject_name: Opioids


subject: CHEBI:35482

subject_name: opioid analgesic


subject: UMLS:C0242402


subject: PUBCHEM.COMPOUND:54585

subject_name: balsalazide

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:54585

object_name: inflammatory bowel disease 1


subject: CHEBI:32139

object_name: aneurysm


subject: UMLS:C5557579

subject_name: AsiDNA

object_name: Advanced cancer


subject: UMLS:C4305741

object_name: pemphigus vulgaris


subject: CHEBI:17968

subject_name: butyrate

object_name: type 2 diabetes mellitus


subject: CHEBI:17968

object_name: Insulin resistance


subject: CHEBI:17968

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:17968

object_name: obesity


subject: CHEBI:17968

object_name: Obesity, CTCAE


subject: MESH:D002087

subject_name: Butyrates


subject: MESH:D002087


subject: MESH:D002087


subject: MESH:D002087


subject: MESH:D002087


subject: CHEBI:30772

subject_name: Butyric Acid


subject: UMLS:C0499134

subject_name: Injection, mesna, 200 mg

object_name: temporomandibular joint disorder


subject: UMLS:C5203568

subject_name: Mesna Liquid Injection


subject: CHEBI:85990

subject_name: Panobinostat

object_name: pancreatic neoplasm


subject: CHEBI:85990

object_name: exocrine pancreatic carcinoma


subject: CHEBI:85990

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Heart failure with normal ejection fraction


subject: PUBCHEM.COMPOUND:2269

object_name: Neglected Tropical Diseases


subject: PUBCHEM.COMPOUND:2269

object_name: Treponema infectious disease


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: PUBCHEM.COMPOUND:138678712

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:138678712

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:138678712

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:138678712

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:138678712

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:138678712

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:138678712

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:138678712

object_name: neoplasm of esophagus


subject: PUBCHEM.COMPOUND:138678712

object_name: malignant pleural mesothelioma


subject: UNII:8L976E3N4N


subject: UNII:8L976E3N4N


subject: UNII:8L976E3N4N


subject: UNII:8L976E3N4N


subject: UNII:8L976E3N4N


subject: UNII:8L976E3N4N


subject: UNII:8L976E3N4N


subject: UNII:8L976E3N4N


subject: UNII:8L976E3N4N


subject: UMLS:C5417900

subject_name: FAK/ALK/ROS1 Inhibitor APG-2449


subject: UMLS:C5417900


subject: UMLS:C5417900


subject: UMLS:C5417900


subject: UMLS:C5417900


subject: UMLS:C5417900


subject: UMLS:C5417900


subject: UMLS:C5417900


subject: UMLS:C5417900


subject: UNII:YNH9K62UXU

subject_name: EFAVALEUKIN ALFA

object_name: inflammatory disease


subject: UMLS:C4687718

subject_name: Fc il-2 mutein fusion protein (amg-592)


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: FLT3 Internal Tandem Duplication


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:135423438

object_name: acute myeloid leukemia with 11q23 abnormalities


subject: PUBCHEM.COMPOUND:135423438

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:135423438


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:230519

subject_name: heparin sodium

object_name: Extracorporeal membrane oxygenation complication


subject: UNII:851NLB57HQ

subject_name: E-DOXEPIN

object_name: irritable bowel syndrome


subject: CHEBI:4710

subject_name: Doxepin


subject: PUBCHEM.COMPOUND:91654792

subject_name: Oratecan

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:91654792

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:91654792

object_name: Solid Neoplasm


subject: UMLS:C2981803


subject: UMLS:C2981803


subject: UMLS:C2981803


subject: UMLS:C0499033

subject_name: Injection, hyaluronidase, up to 150 units administered

object_name: Pre T-ALL


subject: UMLS:C5203330

subject_name: Hyaluronidase Liquid Injection


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase


subject: CHEBI:79068

subject_name: Crocin

object_name: Childhood Breast Carcinoma


subject: CHEBI:79068

object_name: breast carcinoma


subject: CHEBI:79068

object_name: breast cancer


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: anti-NMDA receptor encephalitis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEMBL.COMPOUND:CHEMBL4650516

subject_name: FINOTONLIMAB

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650516

object_name: Klatskin Tumor


subject: UMLS:C5417812

subject_name: Finotonlimab


subject: UMLS:C3273725

object_name: prostate neoplasm


subject: CHEBI:136034

subject_name: Afamelanotide

object_name: solar urticaria


subject: UMLS:C0066889

subject_name: MT-I


subject: UMLS:C3896925

subject_name: Lm-LLO-PSA

object_name: prostate carcinoma


subject: UMLS:C3896925

object_name: prostate cancer


subject: UMLS:C3896925

object_name: cancer


subject: UMLS:C3896925

object_name: neoplasm


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: Carcinoma breast stage IV


subject: CHEBI:46058

subject_name: TAXOTERE


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Microsatellite Stable Colorectal Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: RAS Family Gene Mutation


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:45783

subject_name: Imatinib

object_name: skin neoplasm


subject: UMLS:C0906802

object_name: melanoma


subject: UMLS:C0906802


subject: UMLS:C1722435

object_name: Depressed mood


subject: UMLS:C1722435

object_name: Cancer patients and suicide and depression


subject: UMLS:C1722435

object_name: Depressed - symptom


subject: UMLS:C1722435

object_name: Depression, CTCAE


subject: CHEBI:184910

subject_name: Rotigotine

object_name: end stage renal failure


subject: CHEBI:184910

object_name: Chronic uremia


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C3529783

object_name: Neurogenic claudication


subject: UMLS:C3529783

object_name: Pain in spine


subject: UMLS:C3529783

object_name: radiculopathy


subject: UMLS:C3529783

object_name: bone marrow disorder


subject: UMLS:C3529783

object_name: spinal cord disorder


subject: UMLS:C3529783

object_name: Myelopathy


subject: PR:000006455

subject_name: dehydrodolichyl diphosphate synthase complex subunit DHDDS

object_name: ocular melanoma


subject: PR:000006455

object_name: uveal melanoma


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: Decreased liver function


subject: UMLS:C1172402

object_name: cancer


subject: UMLS:C1172402

object_name: neoplasm


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: spinal muscular atrophy, type III


subject: CHEBI:41500

object_name: spinal muscular atrophy, type II


subject: PUBCHEM.COMPOUND:4479094

subject_name: Doxercalciferol

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:4479094

object_name: leukemia


subject: PUBCHEM.COMPOUND:4479094

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:4479094


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: Stage I Endometrial Carcinoma


subject: UMLS:C2346492

object_name: Endometrial cancer stage II


subject: UMLS:C2346492

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C2346492

object_name: Endometrial cancer stage III


subject: PUBCHEM.COMPOUND:4695

subject_name: Isosulfan blue


subject: PUBCHEM.COMPOUND:4695


subject: PUBCHEM.COMPOUND:4695


subject: PUBCHEM.COMPOUND:4695


subject: UNII:39N9K8S2A4

subject_name: isosulfan blue


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: tuberculosis


subject: CHEBI:51254

object_name: respiratory tract infectious disorder


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:94561

object_name: Chemotherapy-induced nausea and vomiting


subject: UNII:82WI2L7Q6E

subject_name: DOLASETRON


subject: CHEBI:188074


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Abdominal Infection


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Hypoalbuminemia, CTCAE


subject: CHEBI:50733

object_name: Serum albumin level decreased below normal (finding)


subject: CHEBI:50733

object_name: Hypoalbuminemia


subject: CHEBI:50733

object_name: stroke disorder


subject: CHEBI:50733

object_name: cerebrovascular disorder


subject: CHEBI:50733

object_name: Stroke (heart beat)


subject: CHEBI:50733

object_name: Stroke, CTCAE


subject: CHEBI:50733

object_name: Osteopenia


subject: CHEBI:50733

object_name: Malnutrition (calorie)


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: acute myocarditis


subject: CHEBI:131174

subject_name: Navitoclax

object_name: acute lymphoblastic leukemia


subject: CHEBI:44915

subject_name: Propofol

object_name: Depth of anesthesia


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Recurrent Biliary Tract Carcinoma


subject: CHEBI:145371

object_name: Unresectable Biliary Tract Carcinoma


subject: CHEBI:145371

object_name: Stage III Distal Bile Duct Cancer AJCC v8


subject: CHEBI:145371

object_name: Stage IV Distal Bile Duct Cancer AJCC v8


subject: CHEBI:145371

object_name: Advanced Gallbladder Carcinoma


subject: CHEBI:145371

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:145371

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:145371


subject: CHEBI:145371

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v8


subject: CHEBI:145371

object_name: Stage IV Intrahepatic Cholangiocarcinoma AJCC v8


subject: CHEBI:145371

object_name: Stage III Hilar Cholangiocarcinoma AJCC v8


subject: CHEBI:145371

object_name: Stage IV Hilar Cholangiocarcinoma AJCC v8


subject: CHEBI:145371

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:145371

object_name: Recurrent Cancer of Gallbladder


subject: MESH:C487928

subject_name: Promensil

object_name: Childhood Breast Carcinoma


subject: MESH:C487928

object_name: breast carcinoma


subject: MESH:C487928

object_name: breast cancer


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: type 1 diabetes mellitus 1


subject: CHEBI:94531

subject_name: belinostat

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:94531

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:94531

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:94531

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Childhood Malignant Solid Neoplasm


subject: UNII:8M7YSN2KII

object_name: Malignant Solid Neoplasm


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: carcinoma of esophagus


subject: UNII:QEN1X95CIX

object_name: Childhood Esophageal Carcinoma


subject: UNII:QEN1X95CIX

object_name: neoplasm of esophagus


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Female infertility associated with anovulation


subject: CHEBI:32682

subject_name: L-argininium

object_name: high-risk pregnancy


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: DRUGBANK:DB17528

object_name: pancreatic neoplasm


subject: DRUGBANK:DB17528

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB17528

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: UNII:FIJ3OLQ3N8


subject: UNII:FIJ3OLQ3N8


subject: UNII:FIJ3OLQ3N8


subject: UMLS:C2826130

subject_name: Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207


subject: UMLS:C2826130


subject: UMLS:C2826130


subject: UMLS:C4722124


subject: UMLS:C4722124


subject: UMLS:C4722124


subject: UNII:B0L24T8TB7


subject: UNII:B0L24T8TB7


subject: UNII:B0L24T8TB7


subject: UMLS:C1707048

subject_name: broccoli sprout extract

object_name: Tobacco-Related Carcinoma


subject: UMLS:C2347419

object_name: malignant epithelial tumor of ovary


subject: GTOPDB:13403

subject_name: marstacimab

object_name: hemophilia


subject: UNII:0UB3OA67O7


subject: UMLS:C5226892


subject: UMLS:C3813201

subject_name: Oral Rehydration Solution OS-1

object_name: cholera


subject: UMLS:C0078516

subject_name: World Health Organization oral rehydration solution


subject: UMLS:C1443923

subject_name: Oral rehydration solution


subject: CHEBI:64816

object_name: prostate neoplasm


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C5854575

subject_name: Anti-EGFR Antibody-drug Conjugate CPO301

object_name: cancer


subject: UMLS:C5854575

object_name: neoplasm


subject: UMLS:C5854575

object_name: lung cancer


subject: UMLS:C5666939

subject_name: Anti-VISTA Monoclonal Antibody HMBD-002

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5666939

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5666939

object_name: Embolism, Tumor


subject: UMLS:C5666939

object_name: Neoplasm Metastasis


subject: UMLS:C5666939

object_name: Childhood Solid Neoplasm


subject: UMLS:C5666939

object_name: Adult Solid Neoplasm


subject: UMLS:C5666939

object_name: Solid Neoplasm


subject: UMLS:C5666939

object_name: Primary malignant neoplasm


subject: UMLS:C5666939


subject: UMLS:C5666939

object_name: childhood malignant neoplasm


subject: UMLS:C5666939

object_name: Malignant obstetric neoplasm


subject: UMLS:C5666939

object_name: triple-negative breast carcinoma


subject: UMLS:C5666939

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5666939

object_name: tumor suppressor gene on chromosome 11


subject: UMLS:C5666939

object_name: non-small cell lung carcinoma


subject: UMLS:C5666939


subject: UMLS:C5666939


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: malignant testicular germ cell tumor


subject: CHEBI:84094

object_name: neoplasm of testis


subject: CHEBI:84094

object_name: testicular cancer


subject: CHEBI:84094

object_name: Leydig cell failure in adult


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: eye injury trauma


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:55379

subject_name: camphorsulfonic acid

object_name: Inflammation


subject: CHEBI:4031

subject_name: Cyclosporine


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:73462

subject_name: Cys-Ser


subject: CHEBI:30514

subject_name: caesium atom


subject: UMLS:C3658638

object_name: Adenocarcinoma of the prostate stage II


subject: UMLS:C3658638

object_name: Adenocarcinoma of the prostate stage IV


subject: UMLS:C3658638

object_name: Adenocarcinoma of the prostate stage III


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: uveitis


subject: UNII:21K6M2I7AG

object_name: Uveitis, CTCAE


subject: UNII:21K6M2I7AG

object_name: anterior uveitis


subject: UMLS:C0021741

subject_name: Actimmune


subject: CHEBI:68575

subject_name: Indacaterol

object_name: heart failure


subject: CHEBI:68575

object_name: Heart Failure, CTCAE


subject: UMLS:C5417977

subject_name: Wee1 Kinase Inhibitor Debio 0123

object_name: Advanced breast cancer


subject: UMLS:C5554919

subject_name: Dalmitamig

object_name: colorectal carcinoma


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Inflammatory cardiomyopathy


subject: CHEBI:8764


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:230682

subject_name: Indoximod

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:230682

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UNII:W6F4FRQ5QC

subject_name: PULRODEMSTAT

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:W6F4FRQ5QC

object_name: non-Hodgkin lymphoma


subject: UMLS:C4330526


subject: UMLS:C4330526


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:94366


subject: CHEBI:18248

subject_name: Iron

object_name: hemochromatosis type 1


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: CHEBI:109549

subject_name: Ramelteon

object_name: Heartburn


subject: CHEBI:109549

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UNII:NV6352Y6TV

object_name: coronary artery disorder


subject: UNII:NV6352Y6TV

object_name: coronary atherosclerosis


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: recurrent primary peritoneal cavity cancer


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C3659294

object_name: diabetic macular edema


subject: CHEBI:136044

subject_name: Fimasartan

object_name: essential hypertension, genetic


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: fallopian tube cancer


subject: CHEBI:68534

object_name: primary peritoneal carcinoma


subject: CHEBI:68534

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:68534

object_name: peritoneal carcinoma


subject: PUBCHEM.COMPOUND:169155658

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5959393

subject_name: PLK4 Inhibitor RP-1664


subject: UNII:R1SIA15KZ1

subject_name: SOTRASTAURIN ACETATE

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:R1SIA15KZ1

object_name: prolymphocytic leukemia


subject: UNII:R1SIA15KZ1

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:R1SIA15KZ1

object_name: Mantle cell lymphoma recurrent


subject: UNII:R1SIA15KZ1

object_name: Richter syndrome


subject: UMLS:C2825282

subject_name: Sotrastaurin Acetate


subject: UMLS:C2825282


subject: UMLS:C2825282


subject: UMLS:C2825282


subject: UMLS:C2825282


subject: UNII:OJ72N0B4UC

object_name: follicular lymphoma


subject: UMLS:C4727739

subject_name: Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: pancreatitis


subject: CHEBI:6770

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:6770

object_name: Pancreatitis, CTCAE 3.0


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:43968


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: neuroendocrine neoplasm


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Deleterious BRCA1 Gene Mutation


subject: GTOPDB:8313

object_name: Deleterious BRCA2 Gene Mutation


subject: GTOPDB:8313

object_name: invasive breast carcinoma


subject: GTOPDB:8313

object_name: breast adenocarcinoma


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: Non-small cell lung cancer stage III


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: CHEMBL.COMPOUND:CHEMBL4650288

subject_name: FLYSYN

object_name: acute myeloid leukemia by FAB classification


subject: CHEMBL.COMPOUND:CHEMBL4650288

object_name: acute myeloid leukemia


subject: UMLS:C4287796


subject: UMLS:C4287796


subject: UMLS:C5140149

subject_name: Tenecteplase for Injection

object_name: stroke due to basilar artery occlusion


subject: UMLS:C5140149

object_name: basilar artery occlusion


subject: CHEBI:135928

subject_name: Doripenem

object_name: meningitis


subject: CHEBI:135928

object_name: Meningitis, CTCAE


subject: PUBCHEM.COMPOUND:3033637

subject_name: nizatidine

object_name: Heartburn


subject: PUBCHEM.COMPOUND:3033637

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C0678129

subject_name: Axid


subject: UMLS:C0678129


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: HIV infection


subject: CHEBI:91397

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:91397

object_name: Plasma cell myeloma refractory


subject: CHEBI:91397

object_name: testicular lymphoma


subject: CHEBI:91397

object_name: refractory hairy cell leukemia


subject: CHEBI:91397

object_name: small intestine lymphoma


subject: CHEBI:91397

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:91397

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:91397

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:91397

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:91397

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:91397

object_name: multicentric Castleman disease


subject: CHEBI:91397

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: hairy cell leukemia


subject: PUBCHEM.COMPOUND:71226663

object_name: Burkitt lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:71226663

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Childhood Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: PUBCHEM.COMPOUND:44573417

subject_name: METFORMIN XR

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:44573417

object_name: atherosclerosis


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: Adverse Event Associated with Death


subject: UMLS:C3819106

object_name: Death (finding)


subject: UMLS:C3819106

object_name: Death


subject: UNII:DPT0O3T46P

object_name: Premenopausal breast cancer


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:6427

subject_name: Leuprolide


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Neoplasm, Residual


subject: PUBCHEM.COMPOUND:73005958

object_name: bilateral multicystic dysplastic kidney


subject: PUBCHEM.COMPOUND:73005958

object_name: High risk of


subject: PUBCHEM.COMPOUND:73005958

object_name: High risk


subject: PUBCHEM.COMPOUND:73005958

object_name: American College of Cardiology/American Heart Association Lesion Complexity Score C


subject: PUBCHEM.COMPOUND:73005958

object_name: High Risk Acute Leukemia


subject: PUBCHEM.COMPOUND:73005958

object_name: International Prognostic Index High Risk Group


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:132774

subject_name: Roxadustat

object_name: Normal renal function


subject: UMLS:C3713379


subject: UNII:2946IE3VYD

object_name: B-cell lymphoma refractory


subject: UNII:2946IE3VYD

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: UNII:2946IE3VYD

object_name: Refractory Adult Acute Lymphoblastic Leukemia


subject: UNII:2946IE3VYD

object_name: B-cell lymphoma recurrent


subject: UNII:2946IE3VYD

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: UNII:2946IE3VYD

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:2946IE3VYD

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: UNII:2946IE3VYD

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:2946IE3VYD

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:2946IE3VYD

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:2946IE3VYD

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:2946IE3VYD

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: MESH:D016827

subject_name: CD8 Antigens


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEMBL.COMPOUND:CHEMBL2109533

subject_name: ORTICUMAB

object_name: myocardial infarction


subject: CHEMBL.COMPOUND:CHEMBL2109533

object_name: acute coronary syndrome


subject: CHEMBL.COMPOUND:CHEMBL2109533

object_name: heart disorder


subject: UMLS:C5238046

subject_name: Orticumab


subject: UMLS:C5238046


subject: UMLS:C5238046


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: Insulin resistance


subject: UMLS:C2931954

subject_name: MLC 901

object_name: traumatic encephalopathy


subject: UMLS:C2931954

object_name: traumatic brain injury


subject: UMLS:C1508746

subject_name: egg extract

object_name: Egg allergy


subject: UMLS:C1508746

object_name: Cow milk allergy


subject: DRUGBANK:DB10529

subject_name: Egg


subject: DRUGBANK:DB10529


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: DRUGBANK:DB10543


subject: CHEBI:32184

subject_name: Tazarotene

object_name: Trachyonychia


subject: CHEBI:32184

object_name: Fragile nails


subject: CHEBI:32184

object_name: Brittle nails


subject: CHEBI:90620

subject_name: Vatalanib

object_name: glioblastoma


subject: CHEBI:90620

object_name: Childhood Glioblastoma


subject: CHEBI:90620

object_name: adult glioblastoma


subject: UMLS:C0912413

subject_name: PTK 787


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: CHEBI:90623


subject: CHEBI:90623


subject: CHEBI:90623


subject: UMLS:C1524078


subject: UMLS:C1524078


subject: UMLS:C1524078


subject: CHEBI:50114

subject_name: estrogen

object_name: Gender Dysphoria


subject: CHEBI:50114

object_name: gender incongruence


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: fibrosis


subject: PUBCHEM.COMPOUND:16683012

subject_name: Sodium stibogluconate

object_name: Chiclero ulcer


subject: PUBCHEM.COMPOUND:16683013

subject_name: Stibogluconate


subject: CHEBI:28148


subject: UMLS:C0591962

subject_name: Pentostam


subject: CHEBI:7451

subject_name: naftifine

object_name: tinea pedis


subject: CHEBI:48548

subject_name: triflyl group

object_name: prostate carcinoma


subject: CHEBI:48548

object_name: prostate cancer


subject: CHEBI:136609

subject_name: theaflavin


subject: CHEBI:136609


subject: CHEBI:74862

subject_name: Thr-Phe


subject: CHEBI:74862


subject: PUBCHEM.COMPOUND:65121

subject_name: Thomsen-Friedenreich antigen


subject: PUBCHEM.COMPOUND:65121


subject: PUBCHEM.COMPOUND:168009928

subject_name: Keyhole limpet hemocyanin


subject: PUBCHEM.COMPOUND:168009928


subject: UNII:FV4Y0JO2CX

subject_name: keyhole-limpet hemocyanin


subject: UNII:FV4Y0JO2CX


subject: CHEMBL.COMPOUND:CHEMBL5314988

subject_name: KEYHOLE LIMPET HEMOCYANIN


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: peritoneal neoplasm


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:49863420

subject_name: ceftolozane

object_name: pyelonephritis


subject: CHEBI:9421

subject_name: Tazobactam

object_name: Complicated urinary tract infection


subject: CHEBI:9421


subject: CHEBI:177460

subject_name: Salirasib

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:20594489

subject_name: Bremelanotide

object_name: Sexual Arousal Disorder


subject: UMLS:C1311125


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:2735

object_name: mal de Debarquement


subject: PUBCHEM.COMPOUND:2735

object_name: Minimal Disseminated Disease


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:51368

subject_name: Lofexidine

object_name: cocaine abuse


subject: CHEBI:7852

subject_name: Oxycodone

object_name: liver carcinoma


subject: CHEBI:7852

object_name: Inflammation


subject: CHEBI:135005

subject_name: Milnacipran

object_name: irritable bowel syndrome


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: Fractured humerus


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UMLS:C0065423

object_name: autoimmune thrombocytopenic purpura


subject: UNII:0DE9724IHC

subject_name: Protamine

object_name: atrial fibrillation


subject: UNII:0DE9724IHC

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:0DE9724IHC

object_name: Atrial Fibrillation, CTCAE


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Non-Hodgkin's lymphoma refractory


subject: UNII:7XL5ISS668

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C5556668

subject_name: Paltimatrectinib

object_name: Adult Solid Neoplasm


subject: UMLS:C5556668

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: UMLS:C5556668

object_name: desmoplastic small round cell tumor


subject: UMLS:C5556668

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: UMLS:C5556668

object_name: primary brain neoplasm


subject: PUBCHEM.COMPOUND:5320784

subject_name: Pterosin E

object_name: classic phenylketonuria


subject: CHEBI:73224

subject_name: allyl isothiocyanate

object_name: Rhinoconjunctivitis


subject: CHEBI:73224

object_name: Atopic rhinitis


subject: PR:000015174

subject_name: sodium-coupled monocarboxylate transporter 1


subject: PR:000015174


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Arthritis of knee


subject: CHEBI:39585

subject_name: Carbidopa


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: diabetes mellitus


subject: UMLS:C0281549

subject_name: Zenapax


subject: MESH:D007166

subject_name: Immunosuppressive Agents


subject: CHEBI:9241

subject_name: Spironolactone

object_name: kidney failure


subject: CHEBI:9241

object_name: Renal Failure, CTCAE


subject: CHEBI:35526

subject_name: hypoglycemic agent

object_name: spinal disease


subject: UMLS:C0020616

subject_name: Hypoglycemic Agents


subject: UMLS:C0020616


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:50815

subject_name: Norgestimate

object_name: hepatitis C


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Head and neck cancer stage IV


subject: UNII:DPT0O3T46P

object_name: Head and neck cancer stage III


subject: CHEBI:71940

subject_name: Tadalafil

object_name: cancer


subject: CHEBI:71940

object_name: neoplasm


subject: CHEBI:71940

object_name: Head and neck cancer metastatic


subject: CHEBI:71940

object_name: Embolism, Tumor


subject: CHEBI:71940


subject: CHEBI:71940


subject: CHEBI:71940

object_name: Cancer of Neck


subject: CHEBI:71940

object_name: oral cavity cancer


subject: CHEBI:71940

object_name: carcinoma of esophagus


subject: CHEBI:71940

object_name: esophageal cancer


subject: CHEBI:221840

object_name: triple-negative breast carcinoma


subject: CHEBI:221840

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:221840

object_name: Breast cancer recurrent


subject: CHEBI:221840

object_name: Her2-receptor negative breast cancer


subject: CHEBI:221840

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:221840

object_name: Carcinoma breast stage IV


subject: CHEBI:221840

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:221840

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:221840

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:221840

object_name: Recurrent Rectal Cancer


subject: CHEBI:221840

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:221840

object_name: Anal cancer recurrent


subject: CHEBI:221840

object_name: Colon cancer recurrent


subject: CHEBI:221840

object_name: Prostate cancer recurrent


subject: CHEBI:221840

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:221840

object_name: recurrent gastric cancer


subject: CHEBI:221840

object_name: Cervix carcinoma recurrent


subject: CHEBI:221840

object_name: Small intestine carcinoma recurrent


subject: CHEBI:221840

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:221840

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:221840

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:221840

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:221840

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:221840

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:221840

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:221840

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:221840

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:221840

object_name: Recurrent Endometrial Cancer


subject: CHEBI:221840

object_name: untreated metastatic squamous neck cancer with occult primary


subject: CHEBI:221840

object_name: Recurrent ovarian cancer


subject: CHEBI:221840

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:221840

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:221840

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:221840

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:221840

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:221840

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:221840

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:221840

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:221840

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:221840

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:221840

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:221840

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:221840

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:221840

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:221840

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:221840


subject: CHEBI:221840

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:221840

object_name: Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: CHEBI:221840

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:221840

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:221840

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:221840

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:221840

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:221840

object_name: Rectal cancer stage IV


subject: CHEBI:221840

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:221840

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:221840

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:221840

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:221840

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:221840

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:221840

object_name: Anal cancer stage IV


subject: CHEBI:221840

object_name: Stage IV Anal Cancer AJCC v8


subject: CHEBI:221840

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:221840

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:221840

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:221840

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:221840

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:221840

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:221840

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:221840

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:221840

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:221840

object_name: malignant epithelial tumor of ovary


subject: CHEBI:221840

object_name: advanced adult primary liver cancer


subject: CHEBI:221840

object_name: Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: CHEBI:221840

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:221840

object_name: Salivary gland cancer stage IV


subject: CHEBI:221840

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:221840

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:221840

object_name: Ovarian cancer stage IV


subject: CHEBI:221840

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:221840

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:221840

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:221840

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:221840

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:221840

object_name: Cervical carcinoma stage IVB


subject: CHEBI:221840

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:221840

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:221840

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:221840

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:221840

object_name: Cervical carcinoma stage IVA


subject: CHEBI:221840

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:221840

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:221840

object_name: stage IV esophageal cancer


subject: CHEBI:221840

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:221840

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:221840

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:221840

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:221840

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:221840

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:221840

object_name: Stage IV Lip Basal Cell Carcinoma


subject: CHEBI:221840

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:221840

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:221840

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: CHEBI:221840

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:221840

object_name: Plexosarcoma


subject: CHEBI:221840

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:221840

object_name: small intestine adenocarcinoma


subject: CHEBI:221840

object_name: appendix carcinoma


subject: CHEBI:221840

object_name: small intestine leiomyosarcoma


subject: CHEBI:221840

object_name: small intestine lymphoma


subject: CHEBI:221840

object_name: ovarian sarcoma


subject: PUBCHEM.COMPOUND:4616292

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:4616292

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Her2-receptor negative breast cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:4616292

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:4616292

object_name: estrogen receptor-negative breast cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Rectal Cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: progesterone receptor-negative breast cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: Anal cancer recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Colon cancer recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Unresectable Gallbladder Carcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: recurrent gastric cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: Cervix carcinoma recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Small intestine carcinoma recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Oesophageal carcinoma recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Cancer of Gallbladder


subject: PUBCHEM.COMPOUND:4616292

object_name: Malignant neoplasm of gallbladder recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Salivary Gland Cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Ovarian Germ Cell Tumor


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Endometrial Cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: untreated metastatic squamous neck cancer with occult primary


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:4616292

object_name: metastatic gastrointestinal carcinoid tumor


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Lip Basal Cell Carcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: PUBCHEM.COMPOUND:4616292

object_name: Laryngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:4616292

object_name: Carcinoma of the prostate stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:4616292

object_name: Laryngeal verrucous carcinoma recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: PUBCHEM.COMPOUND:4616292

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:4616292

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Rectal cancer stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Rectal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:4616292

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:4616292

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:4616292

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: PUBCHEM.COMPOUND:4616292

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:4616292

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:4616292

object_name: Anal cancer stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Anal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:4616292

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:4616292

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Colon Cancer AJCC v6


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Malignant neoplasm of colon stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:4616292

object_name: malignant epithelial tumor of ovary


subject: PUBCHEM.COMPOUND:4616292

object_name: advanced adult primary liver cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: PUBCHEM.COMPOUND:4616292

object_name: Malignant neoplasm of stomach stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Salivary gland cancer stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Ovarian cancer stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Cervical carcinoma stage IVB


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IVB Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IVA Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Cervical carcinoma stage IVA


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Esophageal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:4616292

object_name: stage IV esophageal cancer


subject: PUBCHEM.COMPOUND:4616292

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Ovarian germ cell cancer stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Lip Basal Cell Carcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:4616292

object_name: Laryngeal verrucous carcinoma stage IV


subject: PUBCHEM.COMPOUND:4616292

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:4616292

object_name: Metastatic Endometrial Carcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: small intestine adenocarcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: appendix carcinoma


subject: PUBCHEM.COMPOUND:4616292

object_name: small intestine leiomyosarcoma


subject: PUBCHEM.COMPOUND:4616292

object_name: small intestine lymphoma


subject: PUBCHEM.COMPOUND:4616292

object_name: ovarian sarcoma


subject: CHEBI:90881

subject_name: Camptosar

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:90881

object_name: Her2-receptor negative breast cancer


subject: CHEBI:90881

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:90881

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:90881

object_name: Anal cancer recurrent


subject: CHEBI:90881

object_name: Prostate cancer recurrent


subject: CHEBI:90881

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:90881

object_name: Cervix carcinoma recurrent


subject: CHEBI:90881

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:90881

object_name: Small cell lung cancer recurrent


subject: CHEBI:90881

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:90881

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:90881

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:90881

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:90881

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:90881

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:90881

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:90881

object_name: Recurrent Endometrial Cancer


subject: CHEBI:90881

object_name: untreated metastatic squamous neck cancer with occult primary


subject: CHEBI:90881

object_name: Recurrent ovarian cancer


subject: CHEBI:90881

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:90881

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:90881

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:90881

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:90881

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:90881

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:90881

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:90881

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:90881


subject: CHEBI:90881

object_name: Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: CHEBI:90881

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:90881

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:90881

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:90881

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:90881

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:90881

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:90881

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:90881

object_name: Anal cancer stage IV


subject: CHEBI:90881

object_name: Stage IV Anal Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:90881

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:90881

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:90881

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:90881

object_name: Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: CHEBI:90881

object_name: Salivary gland cancer stage IV


subject: CHEBI:90881

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: Ovarian cancer stage IV


subject: CHEBI:90881

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:90881

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:90881

object_name: Cervical carcinoma stage IVB


subject: CHEBI:90881

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: Cervical carcinoma stage IVA


subject: CHEBI:90881

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:90881

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:90881

object_name: stage IV esophageal cancer


subject: CHEBI:90881

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:90881

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:90881

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:90881

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:90881

object_name: Stage IV Lip Basal Cell Carcinoma


subject: CHEBI:90881

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:90881

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:90881

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: CHEBI:90881

object_name: Plexosarcoma


subject: CHEBI:90881

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:90881

object_name: appendix carcinoma


subject: CHEBI:90881

object_name: small intestine leiomyosarcoma


subject: CHEBI:90881

object_name: ovarian sarcoma


subject: CHEBI:8988

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:8988

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:8988

object_name: Anal cancer recurrent


subject: CHEBI:8988

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:8988

object_name: Cervix carcinoma recurrent


subject: CHEBI:8988

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:8988

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:8988

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:8988

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:8988

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:8988

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:8988

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:8988

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:8988

object_name: Recurrent Endometrial Cancer


subject: CHEBI:8988

object_name: untreated metastatic squamous neck cancer with occult primary


subject: CHEBI:8988

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:8988

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:8988

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:8988

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:8988

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:8988

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:8988

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:8988

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:8988


subject: CHEBI:8988

object_name: Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: CHEBI:8988

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:8988

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:8988

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:8988

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:8988

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:8988

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:8988

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:8988

object_name: Anal cancer stage IV


subject: CHEBI:8988

object_name: Stage IV Anal Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:8988

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:8988

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:8988

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:8988

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:8988

object_name: Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: CHEBI:8988

object_name: Salivary gland cancer stage IV


subject: CHEBI:8988

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:8988

object_name: Ovarian cancer stage IV


subject: CHEBI:8988

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:8988

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:8988

object_name: Cervical carcinoma stage IVB


subject: CHEBI:8988

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:8988

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:8988

object_name: Cervical carcinoma stage IVA


subject: CHEBI:8988

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:8988

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:8988

object_name: stage IV esophageal cancer


subject: CHEBI:8988

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:8988

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:8988

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:8988

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:8988

object_name: Stage IV Lip Basal Cell Carcinoma


subject: CHEBI:8988

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:8988

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:8988

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: CHEBI:8988

object_name: Plexosarcoma


subject: CHEBI:8988

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:8988

object_name: appendix carcinoma


subject: CHEBI:8988

object_name: small intestine leiomyosarcoma


subject: CHEBI:8988

object_name: ovarian sarcoma


subject: CHEBI:80630

subject_name: Irinotecan

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:80630

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:80630

object_name: Anal cancer recurrent


subject: CHEBI:80630

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:80630

object_name: Cervix carcinoma recurrent


subject: CHEBI:80630

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:80630

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:80630

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:80630

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:80630

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:80630

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:80630

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:80630

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:80630

object_name: Recurrent Endometrial Cancer


subject: CHEBI:80630

object_name: untreated metastatic squamous neck cancer with occult primary


subject: CHEBI:80630

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:80630

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:80630

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:80630

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:80630

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:80630

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:80630

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:80630

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:80630


subject: CHEBI:80630

object_name: Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: CHEBI:80630

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:80630

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:80630

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:80630

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:80630

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:80630

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:80630

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:80630

object_name: Anal cancer stage IV


subject: CHEBI:80630

object_name: Stage IV Anal Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:80630

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:80630

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:80630

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:80630

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:80630

object_name: Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: CHEBI:80630

object_name: Salivary gland cancer stage IV


subject: CHEBI:80630

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:80630

object_name: Ovarian cancer stage IV


subject: CHEBI:80630

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:80630

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:80630

object_name: Cervical carcinoma stage IVB


subject: CHEBI:80630

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:80630

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:80630

object_name: Cervical carcinoma stage IVA


subject: CHEBI:80630

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:80630

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:80630

object_name: stage IV esophageal cancer


subject: CHEBI:80630

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:80630

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:80630

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:80630

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:80630

object_name: Stage IV Lip Basal Cell Carcinoma


subject: CHEBI:80630

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:80630

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:80630

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: CHEBI:80630

object_name: Plexosarcoma


subject: CHEBI:80630

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:80630

object_name: small intestine leiomyosarcoma


subject: CHEBI:80630

object_name: ovarian sarcoma


subject: CHEMBL.COMPOUND:CHEMBL5095122

subject_name: FREXALIMAB

object_name: type 1 diabetes mellitus 1


subject: CHEMBL.COMPOUND:CHEMBL5095122

object_name: type 1 diabetes mellitus


subject: UMLS:C5787323

subject_name: Frexalimab


subject: UMLS:C5787323


subject: CHEBI:64312

subject_name: Memantine

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:64312

object_name: cancer pain


subject: CHEBI:9943

subject_name: Venlafaxine


subject: CHEBI:31596

subject_name: Febuxostat

object_name: Drug Interactions


subject: CHEBI:31596

object_name: Adverse drug interaction


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:GPE7477YEK

subject_name: RIFAMPIN SODIUM


subject: UNII:GPE7477YEK


subject: UMLS:C4543562

subject_name: Rifampin sodium


subject: UMLS:C4543562


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: HIV infection


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: malignant peripheral nerve sheath tumor


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: pancreatic ductal adenocarcinoma


subject: GTOPDB:12966

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:12966

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: GTOPDB:13396

subject_name: ivonescimab


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Diabetic peripheral neuropathy


subject: UMLS:C1527137

object_name: diabetic neuropathy


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: RXCUI:2560233

subject_name: bupivacaine / meloxicam Injectable Product

object_name: Post-Operative Pain


subject: UMLS:C4725176

subject_name: PEOX-based Polymer Encapsulated Paclitaxel FID-007

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4725176

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:134540598

subject_name: ICALCAPRANT

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:134540598

object_name: major depressive disorder


subject: UNII:GNR4JZG668


subject: UNII:GNR4JZG668


subject: UMLS:C5909102

subject_name: Icalcaprant


subject: UMLS:C5909102


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Adult Meningioma


subject: UNII:M89N0Q7EQR

object_name: benign meningioma


subject: UNII:M89N0Q7EQR

object_name: familial meningioma


subject: UNII:M89N0Q7EQR

object_name: pediatric meningioma


subject: UNII:M89N0Q7EQR

object_name: meningioma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEMBL.COMPOUND:CHEMBL4802258

subject_name: ACAPATAMAB

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C5446700

subject_name: Acapatamab


subject: CHEBI:132774

subject_name: Roxadustat

object_name: depression anxiety disorder


subject: UMLS:C3713379


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Intermediate Risk Prostate Carcinoma


subject: DRUGBANK:DB16492

object_name: cutaneous lupus erythematosus


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: UMLS:C0879636

subject_name: IMC C225


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: retinal artery occlusion


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: UMLS:C4721943

object_name: pancreatic neoplasm


subject: UMLS:C2347419


subject: UMLS:C1882413

subject_name: Poly(ADP-ribose) Polymerase Inhibitors


subject: UMLS:C4019076

subject_name: Poly(ADP-Ribose) Polymerase Inhibitor [EPC]


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Amplification of sexual behavior


subject: CHEBI:7465

object_name: Addictive sex behavior


subject: UMLS:C5690380

subject_name: SCB-2020S COVID-19 vaccine


subject: DRUGBANK:DB16181

subject_name: ISIS 2503


subject: DRUGBANK:DB16181

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB16181

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:9909681

subject_name: lasofoxifene

object_name: Carcinoma breast stage IV


subject: UMLS:C4085979

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: CHEBI:4672

subject_name: Docetaxel


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Stage IV adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Plexosarcoma


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:47899

subject_name: red chlorophyll catabolite

object_name: melanoma


subject: CHEBI:47899

object_name: Childhood Solid Neoplasm


subject: CHEBI:47899

object_name: Adult Solid Neoplasm


subject: CHEBI:47899

object_name: Solid Neoplasm


subject: CHEBI:47899

object_name: head and neck squamous cell carcinoma


subject: CHEBI:47899

object_name: non-small cell lung carcinoma


subject: CHEBI:47899

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:47899

object_name: clear cell renal carcinoma


subject: CHEBI:47899

object_name: renal cell adenocarcinoma


subject: CHEBI:47899

object_name: renal cell carcinoma


subject: UMLS:C0796561

subject_name: Melanoma vaccine


subject: UMLS:C0796561


subject: UMLS:C0796561


subject: UMLS:C0796561


subject: UMLS:C0796561


subject: UMLS:C0796561


subject: UMLS:C0796561


subject: UMLS:C0796561


subject: UMLS:C0796561


subject: CHEBI:229764

subject_name: Selinexor

object_name: dedifferentiated liposarcoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Invasive Malignant Neoplasm


subject: CHEBI:4466

object_name: childhood malignant neoplasm


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: peripheral vascular disease


subject: UMLS:C4054493

subject_name: Mimotope-P10s-PADRE Peptide Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C4054493

object_name: breast carcinoma


subject: UMLS:C4054493

object_name: breast cancer


subject: UMLS:C2827521

subject_name: Montanide ISA 51 VG


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C1614968

subject_name: Sativex

object_name: kidney disorder


subject: UMLS:C1614968

object_name: impaired renal function disease


subject: UMLS:C1614968

object_name: kidney failure


subject: CHEBI:176844

subject_name: Niraparib

object_name: Metastatic leiomyosarcoma


subject: CHEBI:176844

object_name: Unresectable Leiomyosarcoma


subject: CHEBI:176844

object_name: Locally Advanced Leiomyosarcoma


subject: CHEBI:176844

object_name: Stage IIIA Retroperitoneal Sarcoma AJCC v8


subject: CHEBI:176844

object_name: Stage III Retroperitoneal Sarcoma AJCC v8


subject: CHEBI:176844

object_name: Stage IIIB Retroperitoneal Sarcoma AJCC v8


subject: CHEBI:176844

object_name: Stage IV Retroperitoneal Sarcoma AJCC v8


subject: UMLS:C5853676

object_name: Myotonia


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: heart valve disorder


subject: UNII:P5TLS56PWW

subject_name: CIZUTAMIG

object_name: EXCESS LMW-DNA


subject: UMLS:C5555828

subject_name: Cizutamig


subject: CHEBI:63724

object_name: fallopian tube cancer


subject: CHEBI:63724

object_name: peritoneum cancer


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: HIV-1 infection


subject: DRUGBANK:DB05726

object_name: cardiovascular disorder


subject: UMLS:C5854489

subject_name: Anti-EpCAM Monoclonal Antibody AM-928

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:94686

subject_name: Orlistat

object_name: heart disorder


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Child Malnutrition


subject: CHEBI:50733

object_name: infant morbidity


subject: PR:000034030

subject_name: FMN reductase (NADH) RutF


subject: CHEBI:139554

subject_name: magnetic nanoparticle


subject: UNII:6D848RA61B

subject_name: Somatrogon

object_name: SHOX-related short stature


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Advanced Pancreatic Adenocarcinoma


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG


subject: UMLS:C1145201

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: UNII:6897GXD6OE

object_name: type 2 diabetes mellitus


subject: UMLS:C5567544

subject_name: Rifaximin 400 mg oral tablet

object_name: Diverticular Diseases


subject: UMLS:C5567544

object_name: digestive system disorder


subject: CHEBI:64073

object_name: Insulin resistance


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: MESH:D020034

subject_name: Silicone Gels

object_name: cleft lip


subject: MESH:D020034

object_name: Cleft lip


subject: CHEBI:78825

subject_name: Avutometinib

object_name: low grade serous adenocarcinoma of ovary


subject: UMLS:C2703210


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: hepatitis B


subject: CHEBI:50693

subject_name: Milrinone

object_name: cardio-renal syndrome


subject: UMLS:C3489433

subject_name: duodopa

object_name: Parkinson disease


subject: UMLS:C3827145

object_name: Refractory Lymphoma


subject: UMLS:C3827145

object_name: CNS metastases


subject: UMLS:C3827145

object_name: Refractory Primary Malignant Central Nervous System Neoplasm


subject: UMLS:C3827145

object_name: Recurrent Primary Malignant Central Nervous System Neoplasm


subject: UMLS:C3827145

object_name: Recurrent Lymphoma


subject: UMLS:C3827145

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C3827145

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C3827145

object_name: Recurrent Diffuse Intrinsic Pontine Glioma


subject: UMLS:C3827145

object_name: Diffuse Midline Glioma, H3 K27-Altered


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079

object_name: carcinoma of esophagus


subject: UMLS:C0919079

object_name: esophageal cancer


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UMLS:C4758796

object_name: colon carcinoma


subject: UMLS:C4758796

object_name: colorectal cancer


subject: UMLS:C4758796

object_name: colon cancer


subject: CHEBI:45783

subject_name: Imatinib

object_name: pancreatic neoplasm


subject: CHEBI:45783

object_name: exocrine pancreatic carcinoma


subject: CHEBI:45783

object_name: malignant pancreatic neoplasm


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: tonsillitis


subject: UMLS:C5763205

subject_name: Tzield

object_name: type 1 diabetes mellitus


subject: UMLS:C5761814

subject_name: teplizumab-mzwv


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:57505028

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:57505028

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:57505028

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:57505028

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:57505028

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:57505028

object_name: mal de Debarquement


subject: PUBCHEM.COMPOUND:57505028

object_name: Minimal Disseminated Disease


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Neonatal hypotension


subject: CHEBI:74705

object_name: Neonatal Hypotension, AE


subject: CHEBI:74705

object_name: Intraoperative Complication


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: UNII:35F0Y2W16Q

subject_name: Felcisetrag

object_name: Gastrointestinal motility disorder


subject: UMLS:C3661040


subject: UNII:6ZA31Y954Z

subject_name: Brodalumab

object_name: rheumatoid arthritis


subject: UNII:9734122TH2

subject_name: Bicyclol

object_name: Drug-Induced Acute Liver Injury


subject: CHEBI:52763


subject: UNII:K5CXA4X5U8

subject_name: relmacabtagene autoleucel

object_name: B-cell non-Hodgkin lymphoma


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: triple-negative breast carcinoma


subject: GTOPDB:13085

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: PUBCHEM.COMPOUND:343523

object_name: pure autonomic failure


subject: PUBCHEM.COMPOUND:343523

object_name: multiple system atrophy


subject: PUBCHEM.COMPOUND:343523

object_name: Lewy Bodies


subject: PUBCHEM.COMPOUND:343523

object_name: Parkinson disease


subject: CHEBI:49166

subject_name: fluorodopa F 18


subject: CHEBI:49166


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: stage IIIB melanoma


subject: CHEBI:4026

object_name: stage IIIC melanoma


subject: CHEBI:4026

object_name: stage IIID melanoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UMLS:C5564908

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEMBL.COMPOUND:CHEMBL4650401

object_name: arterial calcification, generalized, of infancy, 1


subject: UMLS:C5814286


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:2N4O9L084N

object_name: obesity


subject: UNII:2N4O9L084N

object_name: Obesity, CTCAE


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: marginal zone lymphoma


subject: CHEBI:201431

object_name: follicular lymphoma


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3367

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570

object_name: mantle cell lymphoma


subject: CHEBI:9570

object_name: lymphoplasmacytic lymphoma


subject: CHEBI:9570


subject: CHEBI:9570

object_name: prolymphocytic leukemia


subject: CHEBI:9570

object_name: lymphoblastic lymphoma


subject: CHEBI:9570

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:9570


subject: UMLS:C3886729

object_name: Hyperuricemia


subject: UMLS:C3886729

object_name: Hyperuricemia, CTCAE


subject: CHEBI:90929

subject_name: Lesinurad


subject: CHEBI:90929


subject: UMLS:C1449704

subject_name: Fibrates

object_name: glucose metabolism disease


subject: UMLS:C3540783

subject_name: Fibrates, lipid modifying drugs, plain


subject: CHEBI:134024

subject_name: chlorofluorocarbon

object_name: hemophilia


subject: PR:000016127

subject_name: tubulin-specific chaperone C


subject: CHEBI:33216

subject_name: Bisphenol A


subject: PR:000031275

subject_name: dystonin


subject: UMLS:C4723703

subject_name: boron phenylalanine


subject: UMLS:C2054270

subject_name: Tdap vaccine

object_name: group B streptococcal infection


subject: UNII:04NQ160FRU

subject_name: Strontium ranelate

object_name: Fragility fracture


subject: UNII:04NQ160FRU

object_name: Pertrochanteric fracture


subject: UMLS:C3536784

subject_name: cytomegalovirus immune globulin, intravenous

object_name: Disorder of transplanted kidney


subject: UMLS:C3536784

object_name: Complication of transplanted liver


subject: UMLS:C3536784

object_name: cytomegalovirus infection


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: Delayed Graft Function


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Refractory Thyroid Gland Carcinoma


subject: CHEBI:38940

object_name: Unresectable Thyroid Gland Carcinoma


subject: CHEBI:38940

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IV Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:38940

object_name: Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:38940

object_name: thyroid Hurthle cell carcinoma


subject: CHEBI:15383

object_name: irritable bowel syndrome


subject: CHEBI:15383

object_name: Mixed irritable bowel syndrome


subject: CHEBI:15383

object_name: Irritable bowel syndrome with diarrhea


subject: CHEBI:15383

object_name: irritable bowel syndrome with constipation


subject: CHEBI:15384

subject_name: limonene


subject: CHEBI:15384


subject: CHEBI:15384


subject: CHEBI:15384


subject: UMLS:C3714111

object_name: ovarian cancer


subject: UMLS:C3714111

object_name: ovarian neoplasm


subject: UMLS:C3714111

object_name: ovarian carcinoma


subject: UMLS:C3714111

object_name: pancreatic neoplasm


subject: UMLS:C3714111

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3714111

object_name: malignant pancreatic neoplasm


subject: UMLS:C3714111

object_name: small cell lung carcinoma


subject: CHEBI:177705

subject_name: Birinapant

object_name: Solid Neoplasm


subject: UMLS:C2981814


subject: UMLS:C5206629

subject_name: Multi-kinase Inhibitor TT-00420

object_name: malignant soft tissue neoplasm


subject: UMLS:C5206629

object_name: sarcoma


subject: CHEBI:187893

subject_name: Baclofen

object_name: alcohol withdrawal delirium


subject: CHEBI:151315

subject_name: Heparin

object_name: post-thrombotic syndrome


subject: CHEBI:230519

subject_name: heparin sodium

object_name: Deep Venous Thrombosis Related to COVID-19


subject: CHEBI:230519

object_name: Deep venous thrombosis


subject: CHEBI:230519

object_name: venous thromboembolism


subject: CHEBI:230519

object_name: thrombophilia due to thrombin defect


subject: CHEBI:230519


subject: CHEBI:10034

subject_name: warfarin sodium


subject: CHEBI:10034


subject: CHEBI:10034


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:72296

subject_name: Apixaban


subject: CHEBI:119915

subject_name: Fentanyl

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:119915

object_name: obesity


subject: CHEBI:119915

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:166560233

subject_name: ZIDESAMTINIB

object_name: Locally Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:166560233

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5555817

subject_name: TRK/ROS1/ALK Inhibitor SIM1803-1A


subject: UMLS:C5555817


subject: UNII:MX5KQV5XHC


subject: UNII:MX5KQV5XHC


subject: UMLS:C5666993

subject_name: ROS1 Inhibitor NUV-520


subject: UMLS:C5666993


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: leiomyosarcoma


subject: UNII:2CN60TN6ZS

object_name: Childhood Leiomyosarcoma


subject: UNII:2CN60TN6ZS

object_name: Adult Leiomyosarcoma


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Intrapartum hemorrhage


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Disorder related to renal transplantation


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:52717

subject_name: Bortezomib

object_name: systemic sclerosis


subject: CHEBI:52717

object_name: scleroderma


subject: CHEBI:52717

object_name: interstitial lung disease


subject: PUBCHEM.COMPOUND:138115136

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:138115136

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:138115136

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:138115136

object_name: Depression, CTCAE


subject: UMLS:C3661273


subject: UMLS:C3661273


subject: UMLS:C3661273


subject: UMLS:C3661273


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Paraneoplastic sensory ganglionopathy


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: acute coronary syndrome


subject: CHEBI:139072

object_name: Chronic neuropathic pain


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:30742

subject_name: macrogol

object_name: Cystic fibrosis gastrointestinal disease


subject: UNII:6E6VJP68KR

subject_name: AZIMILIDE DIHYDROCHLORIDE

object_name: cardiovascular disorder


subject: UNII:6E6VJP68KR

object_name: heart disorder


subject: PUBCHEM.COMPOUND:60939

subject_name: Azimilide


subject: PUBCHEM.COMPOUND:60939


subject: UMLS:C1314817

subject_name: azimilide dihydrochloride


subject: UMLS:C1314817


subject: CHEBI:30742

object_name: congenital diarrhea 5 with tufting enteropathy


subject: CHEBI:177298

object_name: metastatic colorectal cancer


subject: CHEBI:176844

subject_name: Niraparib


subject: UMLS:C5555865

subject_name: DDX Nanoparticles-encapsulated IL-12 and RIG-I Activating DNA Plasmid EG-70

object_name: superficial urinary bladder carcinoma


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: tuberculosis


subject: CHEBI:185135

subject_name: Polyvidone

object_name: staphylococcus aureus infection


subject: CHEBI:185135

object_name: Dysmotility


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:3732


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: CHEBI:60648


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:47426


subject: CHEBI:29013

subject_name: Fusidic acid


subject: CHEBI:29013


subject: CHEBI:7025

subject_name: Mupirocin


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: UMLS:C4505396

subject_name: High-Dose Trivalent Influenza Vaccine

object_name: myocardial infarction


subject: UMLS:C4505396

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C4505396

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C4505396

object_name: heart failure


subject: UMLS:C4505396

object_name: Heart Failure, CTCAE


subject: UNII:UVJ7NL8S2P

subject_name: Imlifidase

object_name: Renal transplant rejection


subject: PUBCHEM.COMPOUND:22671105

subject_name: Edotecarin

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:22671105

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:54580717

subject_name: KARENITECIN

object_name: melanoma


subject: PUBCHEM.COMPOUND:54580717

object_name: childhood neoplasm


subject: PUBCHEM.COMPOUND:54580717

object_name: neoplastic syndrome


subject: PUBCHEM.COMPOUND:54580717

object_name: cancer or benign tumor


subject: PUBCHEM.COMPOUND:54580717

object_name: neoplasm


subject: CHEBI:177492

subject_name: Cositecan


subject: CHEBI:177492


subject: CHEBI:177492


subject: CHEBI:177492


subject: CHEBI:177492


subject: UMLS:C0913202


subject: UMLS:C0913202


subject: UMLS:C0913202


subject: UMLS:C0913202


subject: UMLS:C0913202


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: RXCUI:151399

subject_name: Bactrim


subject: PUBCHEM.COMPOUND:4358614

subject_name: Telinavir

object_name: HIV infection


subject: UMLS:C4530095

subject_name: varicella zoster virus glycoprotein E, recombinant

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: traumatic encephalopathy


subject: UMLS:C0384570

object_name: traumatic brain injury


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C2825029


subject: UNII:3S182ET3UA

subject_name: TINZAPARIN SODIUM

object_name: renal carcinoma


subject: UNII:3S182ET3UA

object_name: kidney neoplasm


subject: UNII:3S182ET3UA

object_name: kidney cancer


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: CHEBI:31709

subject_name: Iohexol

object_name: Abnormal renal physiology


subject: CHEBI:31709

object_name: disease